Rosetta Genomics Ltd (NASDAQ:ROSG)

3.72
Delayed Data
As of Apr 24
 +0.06 / +1.64%
Today’s Change
2.07
Today|||52-Week Range
5.55
+64.60%
Year-to-Date

Today’s Trading

Previous close3.66
Today’s open3.65
Day’s range3.60 - 3.82
Volume233,439
Average volume (3 months)957,098
Market cap$43.0M
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)+3.73%
Earnings growth (this year)-197.52%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+227.65%
P/E ratio--
Price/Sales19.14
Price/Book2.86

Competitors

 Today’s
change
Today’s
% change
LPTNLpath Inc----
SNGXSoligenix Inc+0.05+2.73%
OXGNOXiGENE Inc0.000.00%
KDUSCadus Corp+0.01+0.70%
Data as of 3:59pm ET, 04/24/2015

Financials

Last reporting dateNovember 7, 2013
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$1.3M
Annual profit (last year)-$14.5M
Net profit margin-1,094.65%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Head-Investor Relations
Kenneth A. Berlin
Chief Financial Officer
Ron Kalfus
Corporate headquarters
Rehovot, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers